Fedratinib is a medication used to treat adults with myelofibrosis, a type of blood cancer. It is a type of drug called a JAK2 inhibitor, which works by blocking the action of a protein called JAK2. This helps to reduce the growth of abnormal cells in the bone marrow and reduce symptoms such as anemia, enlarged spleen, and fatigue. Fedratinib is taken as a tablet once daily. Common side effects include nausea, diarrhea, and headache.
Fedratinib is a medication used to treat a specific type of bone marrow cancer in adults called myelofibrosis [1, 2, 3]. Here's a closer look at its key features:
- Condition: Treats myelofibrosis, a rare cancer where scar tissue builds up in the bone marrow, hindering blood cell production [1, 2, 3].
- Mechanism: Fedratinib is a kinase inhibitor [1, 2, 3]. It targets and blocks specific proteins (kinases) involved in the growth and survival of cancer cells [1, 2, 3].
- Classification: Falls under the category of medications known as JAK inhibitors (Janus kinase inhibitors) [1, 2, 3].
Important things to know about Fedratinib:
- Form: Typically comes in capsule form, taken orally [1, 2, 3].
- Dosage: Usually taken once daily, with or without food [1, 2, 3]. A doctor will determine the appropriate dosage for each patient.
- Side effects: Common side effects include fatigue, nausea, vomiting, diarrhea, and muscle cramps [1, 2, 3]. More serious side effects may also occur, so consulting a doctor is essential for monitoring.
Here are some additional points to consider:
- Fedratinib is a relatively new medication: It's crucial to be aware of the ongoing research on its long-term effects [3].
- Blood count monitoring: Regular blood tests are necessary while taking Fedratinib, as it can affect blood cell counts [1, 2, 3].
- Not a first-line treatment: Doctors may prescribe Fedratinib when other medications haven't been effective [3].
Remember, this information is intended for general knowledge only. It's vital to consult a healthcare professional for diagnosis, treatment advice, and potential risks associated with Fedratinib specific to your situation.